Structural determinants of the specificity for synaptic vesicle-associated membrane protein/synaptobrevin of tetanus and botulinum type B and G neurotoxins

被引:90
作者
Pellizzari, R
Rossetto, O
Lozzi, L
Giovedi, S
Johnson, E
Shone, CC
Montecucco, C
机构
[1] UNIV PADUA,CTR CONSIGLIO NAZL RIC BIOMEMBRANE,I-35100 PADUA,ITALY
[2] UNIV SIENA,DIPARTIMENTO BIOL MOL,SIENA,ITALY
[3] UNIV WISCONSIN,FOOD RES INST,MADISON,WI 53706
[4] PUBL HLTH LAB SERV,CTR APPL MICROBIOL & RES,SALISBURY SP4 0JG,WILTS,ENGLAND
关键词
D O I
10.1074/jbc.271.34.20353
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Tetanus and botulinum neurotoxins type B and G are zinc-endopeptidases of remarkable specificity. They recognize and cleave a synaptic vesicle-associated membrane protein (VAMP)/synaptobrevin, an essential protein component of the vesicle docking and fusion apparatus. VAMP contains two copies of a nine-residue motif, also present in SNAP-25 (synaptosomal-associated protein of 25 kDa) and syntaxin, the two other substrates of clostridial neurotoxins. This motif was suggested to be a determinant of the target specificity of neurotoxins. Antibodies raised against this motif cross-react among VAMP, SNAP-25, and syntaxin and inhibit the proteolytic activity of the neurotoxins. Moreover; the various neurotoxins cross-inhibit each other's proteolytic action. The role of the three negatively charged residues of the motif in neurotoxin recognition was probed by site-directed mutagenesis. Substitution of acidic residues in both copies of the VAMP motif indicate that the first one is involved in tetanus neurotoxin recognition, whereas the second one is implicated in binding botulinum B and G neurotoxins. These results suggest that the two copies of the motif have a tandem association in the VAMP molecule.
引用
收藏
页码:20353 / 20358
页数:6
相关论文
共 45 条
[1]  
BINZ T, 1994, J BIOL CHEM, V269, P1617
[2]  
BLASI J, 1993, EMBO J, V12, P4821, DOI 10.1002/j.1460-2075.1993.tb06171.x
[3]  
BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
[4]   CA2+ REGULATES THE INTERACTION BETWEEN SYNAPTOTAGMIN AND SYNTAXIN-1 [J].
CHAPMAN, ER ;
HANSON, PI ;
AN, S ;
JAHN, R .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (40) :23667-23671
[5]   SOLID-PHASE SYNTHESIS, CONFORMATIONAL-ANALYSIS AND IN-VITRO CLEAVAGE OF SYNTHETIC HUMAN SYNAPTOBREVIN-II-1-93 BY TETANUS TOXIN-L CHAIN [J].
CORNILLE, F ;
GOUDREAU, N ;
FICHEUX, D ;
NIEMANN, H ;
ROQUES, BP .
EUROPEAN JOURNAL OF BIOCHEMISTRY, 1994, 222 (01) :173-181
[6]  
DasGupta B. R., 1994, THERAPY BOTULINUM TO, P15
[7]  
DENTE L, 1987, METHOD ENZYMOL, V155, P111
[8]   BIOGENESIS OF SYNAPTIC VESICLES IN-VITRO [J].
DESNOS, C ;
CLIFTOGRADY, L ;
KELLY, RB .
JOURNAL OF CELL BIOLOGY, 1995, 130 (05) :1041-1049
[9]  
EFFERINK LA, 1989, J BIOL CHEM, V264, P11061
[10]   VESICLE FUSION FROM YEAST TO MAN [J].
FERRONOVICK, S ;
JAHN, R .
NATURE, 1994, 370 (6486) :191-193